Product Information
LANSOPRAZOLE DR 30 MG CAPSULE is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1067 per EA under NDC 67877027590. Its NADAC has been published 330 times since Mar 4, 2020.
Strength
30 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877027590
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LANSOPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207394On Market Since
1/20/2019
Pharmacological Classes
Price Statistics
The NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has been published 330 times since Mar 4, 2020, and over the history we have for it it has declined 37.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1067 per EA |
|---|---|
| All-time high | $0.1828 (Jul 15, 2020) |
| All-time low | $0.0754 (Nov 20, 2024) |
| 52-week high | $0.1104 |
| 52-week low | $0.1049 |
| Median price | $0.1128 |
| Average price | $0.1238 |
| Largest weekly change | -28.6% (Nov 20, 2024) |
| Weeks tracked | 330 |
| Tracking since | Mar 4, 2020 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LANSOPRAZOLE DR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 30 MG CAPSULE, manufactured by Ascend Laboratories, LLC, is $0.1067 per EA (NDC 67877027590), effective Jun 24, 2026.
How has the price of LANSOPRAZOLE DR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has declined 37.0%. It has been tracked across 330 weekly CMS publications since Mar 4, 2020.
What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 30 MG CAPSULE?
Since Mar 4, 2020, the NADAC for LANSOPRAZOLE DR 30 MG CAPSULE has ranged from a low of $0.0754 (Nov 20, 2024) to a high of $0.1828 (Jul 15, 2020), with a median of $0.1128 per EA.
Are there cheaper alternatives to LANSOPRAZOLE DR 30 MG CAPSULE?
8 NADAC-published products share the same active ingredient, strength, and dosage form as LANSOPRAZOLE DR 30 MG CAPSULE, but none are currently priced below it.
Who manufactures LANSOPRAZOLE DR 30 MG CAPSULE?
LANSOPRAZOLE DR 30 MG CAPSULE (NDC 67877027590) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification